2-(4-phenoxyphenyl)-7-(1-(3-(4-(3-carbamoyl-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl)-3-oxopropyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
Zanubrutinib Benzoyl Amide Impurity Racemic is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Zanubrutinib Benzoyl Amide Impurity Racemic for method validation Zanubrutinib Benzoyl Amide Impurity Racemic reference standard Zanubrutinib Benzoyl Amide Impurity Racemic for ANDA filing Zanubrutinib Benzoyl Amide Impurity Racemic for forced degradation studies Zanubrutinib Benzoyl Amide Impurity Racemic identification standard Zanubrutinib Benzoyl Amide Impurity Racemic for DMF filing Zanubrutinib Benzoyl Amide Impurity Racemic HPLC standard Zanubrutinib Benzoyl Amide Impurity Racemic supplier Zanubrutinib Benzoyl Amide Impurity Racemic manufacturer Zanubrutinib Benzoyl Amide Impurity Racemic distributor
